These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 34234000)

  • 21. Use of GeneXpert MTB/RIF on a single pooled sputum specimen to exclude pulmonary tuberculosis among hospital inpatients placed in respiratory isolation.
    Yeong C; Byrne AL; Cho JG; Sintchenko V; Crighton T; Marais BJ
    Int J Infect Dis; 2020 Mar; 92():175-180. PubMed ID: 31881274
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Implementing upfront mobile digital chest x-ray for tuberculosis diagnosis in India-feasibility and benefits.
    Datta B; Prakash A; Ford D; Tripathy JP; Goyal P; Singh S; Singh V; Jaiswal A; Trehan N
    Trans R Soc Trop Med Hyg; 2020 Jul; 114(7):499-505. PubMed ID: 32291437
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Xpert MTB/RIF assay can be used on archived gastric aspirate and induced sputum samples for sensitive diagnosis of paediatric tuberculosis.
    Singh S; Singh A; Prajapati S; Kabra SK; Lodha R; Mukherjee A; Singh V; Hesseling AC; Grewal HM;
    BMC Microbiol; 2015 Sep; 15():191. PubMed ID: 26420261
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association of Radiological Findings with the Xpert MTB/RIF Test in Patients with Suspected Pulmonary Tuberculosis.
    Neto WOE; Pereira GR; Barbosa MS; Dias NJD; Silva DR
    Lung; 2018 Dec; 196(6):755-760. PubMed ID: 30178313
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assessment of the sensitivity and specificity of Xpert MTB/RIF assay as an early sputum biomarker of response to tuberculosis treatment.
    Friedrich SO; Rachow A; Saathoff E; Singh K; Mangu CD; Dawson R; Phillips PP; Venter A; Bateson A; Boehme CC; Heinrich N; Hunt RD; Boeree MJ; Zumla A; McHugh TD; Gillespie SH; Diacon AH; Hoelscher M;
    Lancet Respir Med; 2013 Aug; 1(6):462-70. PubMed ID: 24429244
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increased detection of smear-negative pulmonary tuberculosis by GeneXpert MTB/RIF® assay after bleach concentration.
    Tadesse M; Aragaw D; Rigouts L; Abebe G
    Int J Mycobacteriol; 2016 Jun; 5(2):211-8. PubMed ID: 27242234
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of Xpert® MTB/RIF Assay in Induced Sputum and Gastric Lavage Samples from Young Children with Suspected Tuberculosis from the MVA85A TB Vaccine Trial.
    Bunyasi EW; Tameris M; Geldenhuys H; Schmidt BM; Luabeya AK; Mulenga H; Scriba TJ; Hanekom WA; Mahomed H; McShane H; Hatherill M
    PLoS One; 2015; 10(11):e0141623. PubMed ID: 26554383
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Performance and impact of GeneXpert MTB/RIF® and Loopamp MTBC Detection Kit® assays on tuberculosis case detection in Madagascar.
    Rakotosamimanana N; Lapierre SG; Raharimanga V; Raherison MS; Knoblauch AM; Raherinandrasana AH; Rakotoson A; Rakotonirina J; Rasolofo V
    BMC Infect Dis; 2019 Jun; 19(1):542. PubMed ID: 31221109
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rapid diagnosis of pulmonary tuberculosis in African children in a primary care setting by use of Xpert MTB/RIF on respiratory specimens: a prospective study.
    Zar HJ; Workman L; Isaacs W; Dheda K; Zemanay W; Nicol MP
    Lancet Glob Health; 2013 Aug; 1(2):e97-e104. PubMed ID: 25104164
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Successes, challenges and lessons from a novel deployment of Xpert(®) MTB/RIF at a major South African public event [Short Communication].
    Page-Shipp L; Stevens W; Clark D; Scott L; Olsen F; Kisbey-Green H; Mametja D; Churchyard G
    Int J Tuberc Lung Dis; 2014 Apr; 18(4):438-40. PubMed ID: 24670699
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Testing Pooled Sputum with Xpert MTB/RIF for Diagnosis of Pulmonary Tuberculosis To Increase Affordability in Low-Income Countries.
    Abdurrahman ST; Mbanaso O; Lawson L; Oladimeji O; Blakiston M; Obasanya J; Dacombe R; Adams ER; Emenyonu N; Sahu S; Creswell J; Cuevas LE
    J Clin Microbiol; 2015 Aug; 53(8):2502-8. PubMed ID: 26019204
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of GeneXpert MTB/RIF® on treatment initiation and outcomes of RIF-resistant and RIF-susceptible TB patients in Vladimir TB dispensary, Russia.
    Ershova JV; Volchenkov GV; Somova TR; Kuznetsova TA; Kaunetis NV; Kaminski D; Demikhova OV; Chernousova LN; Vasilyeva IA; Kerr EM; Cegielski JP; Kurbatova EV
    BMC Infect Dis; 2020 Jul; 20(1):543. PubMed ID: 32711457
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combined tests with Xpert MTB/RIF assay with bronchoalveolar lavage fluid increasing the diagnostic performance of smear-negative pulmonary tuberculosis in Eastern China.
    Liu Q; Ji Y; Martinez L; Lu W; Shi X; Wang J; Zeng Y
    Epidemiol Infect; 2020 Dec; 149():e5. PubMed ID: 33436140
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Assessment of the Xpert MTB/RIF assay for diagnosis of tuberculosis with gastric lavage aspirates in children in sub-Saharan Africa: a prospective descriptive study.
    Bates M; O'Grady J; Maeurer M; Tembo J; Chilukutu L; Chabala C; Kasonde R; Mulota P; Mzyece J; Chomba M; Mukonda L; Mumba M; Kapata N; Rachow A; Clowes P; Hoelscher M; Mwaba P; Zumla A
    Lancet Infect Dis; 2013 Jan; 13(1):36-42. PubMed ID: 23134697
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of the Xpert MTB/RIF assay for the diagnosis of pulmonary tuberculosis in a high HIV prevalence setting.
    Theron G; Peter J; van Zyl-Smit R; Mishra H; Streicher E; Murray S; Dawson R; Whitelaw A; Hoelscher M; Sharma S; Pai M; Warren R; Dheda K
    Am J Respir Crit Care Med; 2011 Jul; 184(1):132-40. PubMed ID: 21493734
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mycobacterium tuberculosis detection from oral swabs with Xpert MTB/RIF ULTRA: a pilot study.
    Mesman AW; Calderon R; Soto M; Coit J; Aliaga J; Mendoza M; Franke MF
    BMC Res Notes; 2019 Jun; 12(1):349. PubMed ID: 31221195
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tuberculosis case finding using population-based disease surveillance platforms in urban and rural Kenya.
    Bigogo G; Cain K; Nyole D; Masyongo G; Auko JA; Wamola N; Okumu A; Agaya J; Montgomery J; Borgdorff M; Burton D
    BMC Infect Dis; 2018 Jun; 18(1):262. PubMed ID: 29879917
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Xpert MTB/RIF Ultra assay for the diagnosis of pulmonary tuberculosis in children: a multicentre comparative accuracy study.
    Sabi I; Rachow A; Mapamba D; Clowes P; Ntinginya NE; Sasamalo M; Kamwela L; Haraka F; Hoelscher M; Paris DH; Saathoff E; Reither K
    J Infect; 2018 Oct; 77(4):321-327. PubMed ID: 30036606
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Test characteristics and potential impact of the urine LAM lateral flow assay in HIV-infected outpatients under investigation for TB and able to self-expectorate sputum for diagnostic testing.
    Peter J; Theron G; Chanda D; Clowes P; Rachow A; Lesosky M; Hoelscher M; Mwaba P; Pym A; Dheda K;
    BMC Infect Dis; 2015 Jul; 15():262. PubMed ID: 26156025
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy of the Xpert Mycobacterium tuberculosis/rifampicin assay for diagnosing sputum-smear negative or sputum-scarce pulmonary tuberculosis in bronchoalveolar lavage fluid.
    Yang J; Shen Y; Wang L; Ju L; Wu X; Wang P; Hao X; Sun Q; Yu F; Sha W
    Int J Infect Dis; 2021 Jun; 107():121-126. PubMed ID: 33864923
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.